Charles Schwab
AKAO

Charles Schwab’s Achaogen Inc AKAO Stock Holding History

Charles Schwab’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-210,696
Closed -$97K – 3321
2019
Q1 		$97K Buy
210,696
+66,354
+46% +$69.7K ﹤0.01% 3091
2018
Q4 		$178K Sell
144,342
-2,964
-2% -$7.91K ﹤0.01% 3032
2018
Q3 		$588K Sell
147,306
-9,890
-6% -$59.8K ﹤0.01% 2780
2018
Q2 		$1.36M Sell
157,196
-3,634
-2% -$44.3K ﹤0.01% 2490
2018
Q1 		$2.08M Buy
160,830
+23,114
+17% +$262K ﹤0.01% 2314
2017
Q4 		$1.48M Buy
137,716
+15,032
+12% +$189K ﹤0.01% 2406
2017
Q3 		$1.96M Buy
122,684
+74,384
+154% +$1.42M ﹤0.01% 2293
2017
Q2 		$1.05M Buy
+48,300
New +$1.1M ﹤0.01% 2437
2015
Q2 		– Sell
-10,100
Closed -$99K – 3154
2015
Q1 		$99K Hold
10,100
– – ﹤0.01% 3033
2014
Q4 		$132K Hold
10,100
– – ﹤0.01% 3038
2014
Q3 		$91K Hold
10,100
– – ﹤0.01% 3040
2014
Q2 		$141K Buy
+10,100
New +$141K ﹤0.01% 3049

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Charles Schwab's AKAO Position: Q2 2019 in Review

Charles Schwab sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 210,696 shares — an estimated $97K sold.

Charles Schwab first reported a position in AKAO in Q2 2014 and held it in 12 quarters. The position peaked at $2.08M in Q1 2018. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • Charles Schwab reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • Charles Schwab sold 210,696 Achaogen Inc shares in Q2 2019, an estimated $97K.
  • Charles Schwab first reported a position in Achaogen Inc in Q2 2014 and held it in 12 quarters.
  • Charles Schwab's Achaogen Inc position peaked at $2.08M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.